CVR: 39981610
Secondary names: Stem Therapy ApS, StemCell Evolution ApS, StemCell Dynamics ApS
Previous names: Regenerative Therapeutics IVS
Blue Cell Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Regenerative Therapeutics IVS. The management consists of Søren Paludan Sheikh. The company is owned by SEIER CAPITAL A/S, ANDRÉ ROGACZEWSKI HOLDING II ApS and SPSheikh Holding ApS. In 2025, the company reported a gross profit of DKK -5,780,568 and a net result of DKK -21,221,120 compared with DKK -15,189,850 the year before. Equity amounted to DKK -8,126,690.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med udvikling, behandling og kommercialisering af stamceller og hermed efter ledelsens skøn beslægtet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -5.8 mio. | -21.2 mio. | 4.8 mio. | -8.1 mio. | 9 | |
| 2024 | -3.1 mio. | -15.2 mio. | 14.1 mio. | 13.1 mio. | 12 | |
| 2023 | -742 t. | -15.3 mio. | 10.2 mio. | 8.4 mio. | 14 | |
| 2022 | 852 t. | -12.6 mio. | 10.6 mio. | 9.9 mio. | 12 | |
| 2021 | -844 t. | -14.2 mio. | 14 mio. | 12.5 mio. | 7 | |
| 2020 | -2.9 mio. | -14 mio. | 13.5 mio. | 9.8 mio. | 2 |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.053 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Blue Cell Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -5,780,568, and the net result was DKK -21,221,120.
As of June 29, 2026, SEIER CAPITAL A/S is registered as an owner of Blue Cell Therapeutics ApS with an ownership share of 5%.
As of June 29, 2026, ANDRÉ ROGACZEWSKI HOLDING II ApS is registered as an owner of Blue Cell Therapeutics ApS with an ownership share of 33%.
As of June 29, 2026, SPSheikh Holding ApS is registered as an owner of Blue Cell Therapeutics ApS with an ownership share of 33%.
As of August 8, 2025, Ole Vahlgren has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 8, 2025, Olav Hellebø has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 8, 2025, Anders Vadsholt has left the board of directors of Blue Cell Therapeutics ApS.
As of August 7, 2025, Ole Vahlgren has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -3,052,648, and the net result was DKK -15,189,850.
As of December 31, 2024, Sebastian Wehle has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -741,530, and the net result was DKK -15,288,373.
As of April 11, 2024, Anders Vadsholt has joined the board of directors of Blue Cell Therapeutics ApS.
As of April 11, 2024, Sebastian Wehle has joined the board of directors of Blue Cell Therapeutics ApS.
As of October 20, 2023, Anella Rogaczewski has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 24, 2023, Michael Ulveman has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 24, 2023, Ole Vahlgren has joined the board of directors of Blue Cell Therapeutics ApS.
As of August 23, 2023, Michael Ulveman has left the board of directors of Blue Cell Therapeutics ApS.
As of August 23, 2023, Ole Vahlgren has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK 852,135, and the net result was DKK -12,569,961.
As of January 30, 2023, Casper Tind Hansen has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK -843,696, and the net result was DKK -14,241,408.
As of February 3, 2022, André Rafal Rogaczewski has left the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its annual report for 2020. Gross profit came to DKK -2,943,601, and the net result was DKK -14,026,899.
As of July 8, 2021, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Blue Cell Therapeutics ApS.
As of June 23, 2021, Casper Tind Hansen has joined the board of directors of Blue Cell Therapeutics ApS.
As of June 23, 2021, Ole Vahlgren has joined the board of directors of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS has published its interim report for the period October 28, 2018 – December 31, 2019.
As of March 30, 2020, Michael Ulveman has joined the board of directors of Blue Cell Therapeutics ApS.
As of March 30, 2020, André Rafal Rogaczewski has joined the board of directors of Blue Cell Therapeutics ApS.
As of March 30, 2020, Thomas Tofte Hansen has left the board of directors of Blue Cell Therapeutics ApS.
As of March 30, 2020, Leif Helth Jensen has left the board of directors of Blue Cell Therapeutics ApS.
On March 30, 2020, the company changed its name from Regenerative Therapeutics IVS to Blue Cell Therapeutics ApS.
As of February 4, 2019, Thomas Tofte Hansen has joined the board of directors of Blue Cell Therapeutics ApS.
As of February 4, 2019, Søren Paludan Sheikh has joined the board of directors of Blue Cell Therapeutics ApS.
As of February 4, 2019, Leif Helth Jensen has joined the board of directors of Blue Cell Therapeutics ApS.
As of February 4, 2019, Søren Paludan Sheikh is registered as adm. dir. of Blue Cell Therapeutics ApS.
As of February 4, 2019, Thomas Tofte Hansen has stepped down as adm. dir. of Blue Cell Therapeutics ApS.
As of October 28, 2018, Thomas Tofte Hansen is registered as adm. dir. of Blue Cell Therapeutics ApS.
Blue Cell Therapeutics ApS was founded on October 28, 2018.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 40766383
CVR 42731323
CVR 38599119
companydata.dk